Orphan Europe is a pharmaceutical company exclusively dedicated to orphan drugs for the treatment of rare diseases. Founded in 1990, today it has subsidiaries in most European countries, as well as the Middle East. It has acquired a unique experience in the development and distribution of orphan drugs providing over ten different medicinal products to patients all over the world.

Orphan Europe is committed to the improvement of knowledge and awareness about rare disorders. By working closely with health care professionals and patient groups it develops a wide variety of services including the Orphan Europe Academy.